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Over the past years considerable progress has been
made in the field of cardiovascular magnetic reso-
nance (CMR), providing accurate evaluation of left
ventricular mass, volumes and function [1–9]. CMR
has shown unique abilities in characterizing myocar-
dial tissue composition. In particular, high-resolution
contrast-enhanced CMR has been used to visualize
myocardial fibrosis with a high accuracy [10–16]. For
instance, in patients with acute myocardial infarction,
the injured myocardium shows increased CMR
contrast compared to normal myocardium when
imaged by delayed gadolinium enhancement. The
transmural extent of delayed gadolinium enhance-
ment predicts functional outcome after interventional
procedures performed in patients with acute myocar-
dial infarction and chronic ischemic heart disease
[16–21]. Not only in the setting of an acute myocar-
dial infarction, but also in patients with various
manifestations of cardiomyopathy, evidence of
delayed gadolinium enhancement may have impor-
tant clinical and prognostic implications [22–30].
Magnetic resonance angiography (MRA) has been
introduced as a method that can provide visualization
of all three major coronary arteries, coronary
bypasses and the aorta within a single three-dimen-
sional acquisition [31–40]. CMR has become the first
choice imaging modality in complex congenital heart
disease and imaging great vessels [41–46]. In partic-
ular, CMR has proven to be of indispensable value in
identifying aortic stiffness in Marfan patients using
pulse wave velocity measurements [47, 48]. In these
patients pulse wave velocity is the propagation speed
of the pressure or flow wave front traveling along the
aorta. For instance, it has been shown that aortic
stiffness in Marfan syndrome, together with mean
blood pressure, is reduced by beta-blocker therapy,
and CMR is well suited to detect these changes by
measuring aortic distensibility and pulse wave
velocity.
In the present issue of the International Journal of
Cardiovascular Imaging, Brandts et al. [49] investi-
gated in type-1 diabetes mellitus patients the role of
hypertension and of diabetes mellitus itself on aortic
stiffness by using CMR. The hypothesis of the study
was that hypertension has a predominant effect on
aortic stiffness in type-1 diabetes mellitus patients. In
addition, it was established to what extent type-1
diabetes mellitus itself independently adds to aortic
stiffness. Subjects were divided into 4 groups: 32
healthy volunteers, 20 diabetes mellitus patients, 31
hypertensive patients, and 28 patients with both
diabetes mellitus and hypertension. Aortic stiffness
was measured by means of pulse wave velocity using
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velocity-encoded CMR (Medis, Leiden). Mean aortic
pulse wave velocity was 5.7 ± 1.2 m/s in healthy
volunteers, 5.9 ± 1.2 m/s in diabetes mellitus patients
without hypertension, 7.3 ± 1.2 m/s in hypertensive
patients, and 7.3 ± 1.3 m/s in patients with both
diabetes mellitus and hypertension. Compared to
healthy control subjects, aortic pulse wave velocity
was significantly higher in patients with hypertension
and in patients with both diabetes mellitus and
hypertension. However, aortic pulse wave velocity
was not increased in patients having diabetes mellitus
alone. The authors concluded that hypertension has a
predominant contributive effect on aortic stiffness in
diabetes mellitus patients whereas the direct diabetic
effect on aortic stiffness was insignificant.
The main finding of the study was that the
independent effect of type-1 diabetes mellitus on
aortic pulse wave velocity was minor; aortic pulse
wave velocity was not significantly different between
healthy volunteers and type-1 diabetes mellitus
patients. Secondly, the independent effect of hyper-
tension on aortic pulse wave velocity was most
important; aortic pulse wave velocity was significantly
higher in hypertensive patients than in healthy volun-
teers. In addition, the combination of type-1 diabetes
mellitus and hypertension resulted in increased aortic
stiffness, and was significantly higher than in patients
having type-1 diabetes mellitus alone. Interestingly,
the authors showed that aortic stiffness in type-1
diabetes patients mainly depends on having additional
hypertension, and not on diabetes alone. Therefore,
identification of hypertension in patients with type-1
diabetes is of importance for risk stratification and can
be used for guiding therapy in order to improve
cardiovascular outcome.
Investigating the hypertensive contribution on
aortic stiffness in patients with type-1 diabetes
mellitus is utmost relevant for cardiovascular risk
assessment as type-1 diabetes mellitus is often
associated with hypertension. The current study is
unique in the sense that it used CMR-assessed pulse
wave velocity measurements. More recent studies
from the same group showed that stiffness of the
aorta was independently associated with systolic left
ventricular function [50]. In addition, aortic stiffness
independently predicted white matter brain atrophy in
patients with type-1 diabetes mellitus [51].
In summary, the study by Brandts et al. [49], using
CMR-determined pulse wave velocity measurements,
convincingly demonstrates that hypertension has a
predominant contributive effect on aortic stiffness in
diabetes mellitus type-1 patients, whereas the direct
diabetic effect on aortic stiffness was very small.
Since aortic stiffness and diabetes mellitus are highly
associated with adverse cardiovascular events, iden-
tifying hypertension in diabetes mellitus type-1
patients seems utmost relevant for further risk
stratification.
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